Jiangsu Hengrui Medicine 483, Nov 2016

Jiangsu Hengrui Medicine 483, Nov 2016

Peter Baker FDA, Christopher Middendorf FDA$119.00

FDA investigators audited the Jiangsu Hengrui Medicine facility in Lianyungang, China and issued inspectional observations (via FDA 483) on 02 Nov 2016.

Buy This DocumentBuy 1-Year 483 Access

Product details

  • Inspection end: 02 Nov 2016
  • Location: Lianyungang, China